B Braun Medical Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for B BRAUN MEDICAL INC, and when can generic versions of B BRAUN MEDICAL INC drugs launch?
B BRAUN MEDICAL INC has eleven approved drugs.
There are two US patents protecting B BRAUN MEDICAL INC drugs.
There are twenty-seven patent family members on B BRAUN MEDICAL INC drugs in twenty-seven countries and fifty-nine supplementary protection certificates in fifteen countries.
Summary for B Braun Medical Inc
| International Patents: | 27 |
| US Patents: | 2 |
| Tradenames: | 11 |
| Ingredients: | 10 |
| NDAs: | 11 |
| Drug Master File Entries: | 21 |
Drugs and US Patents for B Braun Medical Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun Medical Inc | CLOROTEKAL | chloroprocaine hydrochloride | SOLUTION;INTRATHECAL | 208791-001 | Sep 26, 2017 | DISCN | Yes | No | 9,504,666 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| B Braun Medical Inc | CLOROTEKAL | chloroprocaine hydrochloride | SOLUTION;INTRATHECAL | 208791-001 | Sep 26, 2017 | DISCN | Yes | No | 8,969,412 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| B Braun Medical Inc | MAGNESIUM SULFATE | magnesium sulfate | INJECTABLE;INJECTION | 207967-001 | Apr 26, 2021 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| B Braun Medical Inc | MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER | meropenem | POWDER;INTRAVENOUS | 202106-001 | Apr 30, 2015 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| B Braun Medical Inc | CALCIUM GLUCONATE | calcium gluconate | SOLUTION;INTRAVENOUS | 216541-001 | Aug 21, 2023 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for B Braun Medical Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Slovenia | 1931304 | ⤷ Subscribe |
| Serbia | 53077 | ⤷ Subscribe |
| Cyprus | 1114743 | ⤷ Subscribe |
| Israel | 239270 | ⤷ Subscribe |
| Portugal | 1931304 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for B Braun Medical Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0126587 | 96C0023 | Belgium | ⤷ Subscribe | PRODUCT NAME: MEROPENEM TRIHYDR; NAT. REGISTRATION NO/DATE: 624 IS 88 F 12 19960205; FIRST REGISTRATION: IT 028949028 19940817 |
| 0126587 | SPC/GB95/030 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: MEROPENEM OPTIONALLY IN THE FORM OF A HYDRATE AND /OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: IT 99/1994 19940817; UK 12619/0097 19950119; UK 12619/0098 19950119; UK 12619/0099 19950119; UK 12619/0100 19950119 |
| 0162036 | 2000C/032 | Belgium | ⤷ Subscribe | PRODUCT NAME: LEVETIRACETAM; NAT. REGISTRATION NO/DATE: EU/1/00/146/001 20000929; FIRST REGISTRATION: CH 55297 20000329 |
| 0984957 | 300483 | Netherlands | ⤷ Subscribe | PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMTRIHYDRAAT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105 |
| 0521471 | C300125 | Netherlands | ⤷ Subscribe | PRODUCT NAME: ROSUVASTATINUM, DESGEWENST IN DE VORM VAN EEN NIET-TOXISCH FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET CALCIUMZOUT; REGISTRATION NO/DATE: RVG 26872 - RVG 26874 20021106 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
